Timing of clear-fluid fasting before a liver transplant

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational project will enroll adults scheduled for elective liver transplant at the University Clinical Centre of the Medical University of Warsaw. Researchers will record each patient's reported duration of preoperative clear-fluid fasting and collect hemodynamic (blood pressure, heart rate) and metabolic (blood glucose, lactate, acid–base) measurements at defined anesthesia and transplant phases. Patients unable to provide reliable fasting information because of severe hepatic encephalopathy or cognitive impairment are excluded. No interventions will be assigned; the analysis will focus on associations between fasting duration and intraoperative physiologic changes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* patients scheduled for elective liver transplant

Exclusion Criteria:

* patients unable to give detailed answer on clear fluid fasting due to severe hepatic encephalopathy or cognitive impairment
* lack of written informed consent

Where it's running

• University Clinical Centre of Medical University of Warsaw
  Warsaw, Warszawa, Poland Recruiting

Study contacts

• Study coordinator: Paula Dudek, Medical Doctor
• Email: paula.dudek@wum.edu.pl
• Phone: +49225992001

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Peer support for liver transplant recipients with a history of alcohol use disorder

  This study tests whether having a peer support specialist helps liver transplant recipients with prior alcohol use disorder stay abstinent and stay engaged in care.

  Recruiting Johns Hopkins University · Baltimore, Maryland · NCT07397598

• RSV vaccine safety and immune response in lung transplant patients vs. healthy adults

  This study tests how well the RSV vaccine works and how safe it is in people who have had a lung transplant compared with healthy adults.

  Recruiting Phase 4 Seoul National University Hospital · Seoul, Jongno-Gu · NCT07895394

• Letermovir plus standard antiviral to clear CMV in lung transplant recipients

  This will test whether adding letermovir to usual antiviral treatment helps clear CMV in lung transplant recipients with active infection by week 3.

  Recruiting Phase 4 University Health Network, Toronto · Toronto, Ontario · NCT07235683

• UV-treated, antiviral-protected lungs from Hepatitis B–positive donors for transplant

  This will try using lungs from hepatitis B–positive donors that are treated with UV light during ex vivo lung perfusion plus post-transplant antiviral medicines to see if they can be safely transplanted into HBV-negative lung transplant candidates.

  Recruiting Phase 4 University Health Network, Toronto · Toronto, Ontario · NCT07189377

• Prospective blood collection to detect donor-derived cell-free DNA after kidney transplant

  This project will collect blood from adults who had a kidney transplant to try a blood test that detects donor-derived cell-free DNA to check the transplanted organ.

  Recruiting at 6 sites Devyser Inc. · San Diego, California and 6 other locations · NCT07006831

• Registry for organ transplant recipients and donors at the University of Minnesota

  This study is collecting information from organ transplant recipients and donors to help improve the understanding and management of transplant outcomes.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT01062581

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.